Blog

dsm-firmenich is a global leader in health, nutrition, and biomedical innovation, combining over 150 years of scientific heritage with advanced biomaterials and medical device co-development expertise. As an ATiO Strategic Partner, dsm-firmenich plays a key role in advancing muskuloskeletal therapies through innovative materials, regulatory-ready solutions, and collaborative development—supporting ATiO’s mission to accelerate the translation of advanced therapies into clinical impact.

Discover ATiO’s newly launched membership system, created to unite researchers, clinicians, industry leaders, the finance sectors and innovators from across the globe. The program strengthens collaboration, supports cross-disciplinary exchange and offers exclusive opportunities within the ATiO community — including a limited Founding Membership available only until 30 June 2026.

Prof. Tobias Winkler, Executive Board Chair of ATiO, has been appointed Treasurer of the European Hip Society (EHS). This recognition highlights his international leadership in musculoskeletal medicine and strengthens the alignment between ATiO and one of Europe’s leading orthopaedic societies.

We are pleased to announce a new partnership between the Advanced Therapies in Orthopaedics Foundation (ATiO) and the International Cartilage Regeneration & Joint Preservation Society (ICRS).

Experience the highlights of ATiO Conference 2025 in our curated photo gallery. The collection documents pivotal presentations, collaborative exchanges, and the distinguished experts whose contributions shaped this year’s programme. Whether you joined us in Berlin or are reviewing the event remotely, these images offer a concise, polished record of the scientific insight and collegial spirit that define the ATiO community.

We are excited to welcome Bob Smith to the ATiO Foundation Advisory Board. With over 35 years of experience in gene therapy, rare diseases, and biopharmaceutical leadership, Smith brings invaluable expertise to ATiO’s mission of advancing regenerative and orthopaedic therapies.

ZuriMed has won the ATiO Early-Stage Pitch Contest at the ATiO Conference 2024 with their innovative Surgical FibreLock Technology. This groundbreaking technology offers new possibilities in surgery and impressed the audience with its efficiency and precision. The victory highlights ZuriMed's position as an uprising company in the medical technology field. Find out more!

Discover the vibrant energy and memorable moments of the ATiO Conference 2024.  Our gallery offers a visual journey through the conference, highlighting the key moments and the people who made them happen. Whether you attended in person or are catching up from afar, these photographs provide a rich, colorful recap of an inspiring gathering.